Chemed Corp

Chemed Corp VP buys 199 shares amid $300M buy‑back plan, signaling confidence in stock value and steady $0.60 dividend.

Insider buying at Chemed Corp signals CEO confidence: Wherley Joel L’s latest trade aligns with performance‑based PSUs, a $300 m buyback, and steady dividends, hinting at potential upside for long‑term investors.

Chemed Corp insider moves: CFO Witzeman sells and buys PSUs, boosting confidence in the $300 M buy‑back and $0.60 dividend strategy.

Chemed’s CEO buys shares amid a $300 m buy‑back and $0.60 dividend, showing confidence in the healthcare services firm’s growth and shareholder returns.

Chemed insider buy by VP Brian Judkins signals confidence amid flat share price, buy‑back program, and $0.60 quarterly dividend, boosting investor optimism.